Literature DB >> 6122694

Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.

S E File, A J Bond, R G Lister.   

Abstract

In 18 normal volunteers, lorazepam (2.5 mg) compared with placebo significantly impaired performance in a verbal learning task, in the digit-symbol substitution test, and in symbol copying and number cancellation tasks. These impairments were found equally in subjects with high and low state anxiety and in subjects with high and low trait anxiety. Caffeine citrate (125 to 500 mg) significantly improved performance on the digit-symbol substitution test when given alone and reduced the lorazepam impairment. In the symbol copying test caffeine counteracted the lorazepam impairment. Lorazepam produced a significant loss of appetite and made the subjects feel significantly more dizzy, physically and mentally tired, withdrawn and tranquil, and significantly less anxious. Caffeine citrate (500 mg) counteracted the lorazepam effect of reducing anxiety and making the subjects feel more relaxed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6122694

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  25 in total

1.  Central and peripheral effects of sustained caffeine use: tolerance is incomplete.

Authors:  Joanne Watson; Ian Deary; David Kerr
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

2.  The association of coffee consumption and oxygen desaturation index during sleep among Japanese male workers.

Authors:  Asuka Takabayashi; Koutatsu Maruyama; Yasuhiko Tanno; Susumu Sakurai; Eri Eguchi; Hiroo Wada; Ryutaro Shirahama; Isao Saito; Takeshi Tanigawa
Journal:  Sleep Breath       Date:  2019-02-26       Impact factor: 2.816

3.  Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.

Authors:  G C Preston; C Ward; C R Lines; P Poppleton; J R Haigh; M Traub
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Reinforcing and subjective effects of caffeine in normal human volunteers.

Authors:  K N Stern; L D Chait; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  A comparison of the amnesic effects of lorazepam in alcoholics and non-alcoholics.

Authors:  J L Mallick; K C Kirkby; F Martin; M Philp; M J Hennessy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  The nature of lorazepam-induced amnesia.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys.

Authors:  D M Thompson; A Guidotti; M DiBella; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

8.  Do lorazeam-induced deficits in learning result from impaired rehearsal, reduced motivation or increased sedation?

Authors:  S E File; R G Lister
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

9.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

10.  Absence of central effects in man of the benzodiazepine antagonist Ro 15-1788.

Authors:  A Darragh; R Lambe; C O'Boyle; M Kenny; I Brick
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.